Complementary and Alternative Medicines for the Treatment of Hepatitis C: Perspectives of Users and CAM Practitioners.

Salamat Ali Shahan Ullah Vibhu Paudyal Mashhood Ali Muhammad Khalid Tipu Tofeeq Ur-Rehman

Published in: Evidence-based complementary and alternative medicine : eCAM (2020)

Patients' beliefs in CAM, side effects of allopathic therapy, high cost of allopathic medicines, and referrals from previous CAM users are key factors in the switching of hepatitis C patients to CAM.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
primary care
bone marrow
mesenchymal stem cells
patient reported
combination therapy